相关实验视频

Updated: Jul 19, 2025

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Published on: January 17, 2025

诚实,开放,自豪 (HOP) 对于香港精神疾病患者:一个随机对照试验

Amanda C M Li¹, Winnie W S Mak², Kelly K Y Chan¹

¹Department of Psychology, The Chinese University of Hong Kong, Hong Kong, China.

Social psychiatry and psychiatric epidemiology

|August 15, 2023

概括

诚实,开放,自豪 (HOP) 干预改善了精神疾病患者的乐观情绪,但没有显著影响自我耻辱或恢复. 需要进一步的研究来增强HOP.

科学领域:

心理健康研究心理健康研究
心理社会干预心理社会干预
污名化研究研究

背景情况:

自我耻辱会对精神疾病的恢复产生负面影响,隐和披露会带来挑战.
披露可以减少自我耻辱,提高自尊,增强赋权.
诚实,开放,自豪 (HOP) 是一个同行主导的干预,促进知情披露决策.

研究的目的:

为了评估HOP干预的有效性.
评估HOP对隐藏动机,赋权,自我耻辱,耻辱压力和恢复的影响.
为了检查在香港生活过精神疾病经验的个人的结果.

主要方法:

162名患有精神疾病的参与者被随机分配到干预或等候名单对照组.
干预组接受了6次HOP组干预.
用权力,自我耻辱,耻辱压力和恢复等级来衡量结果.

主要成果:

与对照组相比,HOP干预组的乐观度得分显著改善.
这种乐观情绪的改善在1个月的随访中持续了下去.
在其他测量变量 (如自我耻辱或恢复) 中没有发现显著变化.

结论:

霍普干预表明,它对参与者的乐观情绪产生了积极影响.
该研究没有发现对其他关键结果的显著影响.
建议对HOP干预进行进一步的修改,以便在当地环境中获得更大的益处.

关键词:

骄傲地走出来的骄傲披露披露披露披露诚实,开放,自豪,骄傲的人.自我污名化是一种自我耻辱.污名化是一种耻辱.耻辱化压力是一种压力.

更多相关视频

Comparing Eye-tracking Data of Children with High-functioning ASD, Comorbid ADHD, and of a Control Watching Social Videos

Comparing Eye-tracking Data of Children with High-functioning ASD, Comorbid ADHD, and of a Control Watching Social Videos

Published on: December 7, 2018

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

相关概念视频

Community Based Intervention

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Blind Procedures

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.